Kayentis and ClinOne join forces to improve efficiency and patient experience in clinical trials
ABL and RD-Biotech sign strategic partnership in cell and gene therapy GMP manufacturing
ABL and Imugene partner to advance oncolytic virus candidate towards later phase clinical trials
ABL partners with KaliVir Immunotherapeutics to advance development of oncolytic viruses
ABL and Coave Therapeutics enter into strategic collaboration to develop gene therapy manufacturing processes and create joint capabilities for process development of AAV-based gene therapy
AdBio partners welcomes Inserm Transfert as investor in second fund – AFB Fund II
Nosopharm signs partnership with INRAE and University of Montpellier to develop new anti-infectives
Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
